NAV: 19 Apr 2024 | ₹18.71 |
Min. SIP amount | Not Supported |
Rating | NA |
Fund size | ₹643.07Cr |
3M | 6M | 1Y | All | |
---|---|---|---|---|
Fund returns | 8.5% | 23.9% | 50.2% | 31.4% |
Category average | NA | NA | 48.1% | NA |
Rank with in category | 4 | 12 | 9 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 26.80% |
Cipla Ltd. | Healthcare | Equity | 12.03% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 11.48% |
Divi's Laboratories Ltd. | Healthcare | Equity | 6.72% |
Lupin Ltd. | Healthcare | Equity | 5.98% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 4.69% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 3.90% |
Alkem Laboratories Ltd. | Healthcare | Equity | 3.80% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.64% |
Ipca Laboratories Ltd. | Healthcare | Equity | 2.55% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |